Found 9 hits in this display Target/Host
(Institution) | Ligand | Target/Host
Links | Ligand
Links | Trg + Lig
Links | Ki
nM | ΔG°
kJ/mole | IC50
nM | Kd
nM | EC50/IC50
nM | koff
s-1 | kon
M-1s-1 | pH | Temp
°C |
|---|
Glycogen synthase kinase-3 beta
(Homo sapiens (Human)) | BDBM50540741
(CHEMBL4640019)Show SMILES OCc1cncc(c1)-c1ccc2[nH]nc(C(=O)NCC3CCOCC3)c2c1 Show InChI InChI=1S/C20H22N4O3/c25-12-14-7-16(11-21-9-14)15-1-2-18-17(8-15)19(24-23-18)20(26)22-10-13-3-5-27-6-4-13/h1-2,7-9,11,13,25H,3-6,10,12H2,(H,22,26)(H,23,24) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
| PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | 4 | n/a | n/a | n/a | n/a | n/a | n/a |
Angelini Pharma S.p.A.
Curated by ChEMBL
| Assay Description
Inhibition of recombinant full length human N-terminal GST-tagged GSK3beta (1 to 420 end residues) expressed in baculovirus expression system using u... |
ACS Med Chem Lett 11: 825-831 (2020)
Article DOI: 10.1021/acsmedchemlett.9b00633
BindingDB Entry DOI: 10.7270/Q2930XQ1 |
More data for this
Ligand-Target Pair | |
Dual specificity tyrosine-phosphorylation-regulated kinase 1A
(Homo sapiens (Human)) | BDBM50540741
(CHEMBL4640019)Show SMILES OCc1cncc(c1)-c1ccc2[nH]nc(C(=O)NCC3CCOCC3)c2c1 Show InChI InChI=1S/C20H22N4O3/c25-12-14-7-16(11-21-9-14)15-1-2-18-17(8-15)19(24-23-18)20(26)22-10-13-3-5-27-6-4-13/h1-2,7-9,11,13,25H,3-6,10,12H2,(H,22,26)(H,23,24) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | <10 | n/a | n/a | n/a | n/a | n/a | n/a |
Angelini Pharma S.p.A.
Curated by ChEMBL
| Assay Description
Inhibition of human DYRK1A in presence of ATP |
ACS Med Chem Lett 11: 825-831 (2020)
Article DOI: 10.1021/acsmedchemlett.9b00633
BindingDB Entry DOI: 10.7270/Q2930XQ1 |
More data for this
Ligand-Target Pair | |
Tyrosine-protein kinase Lyn
(Homo sapiens (Human)) | BDBM50540741
(CHEMBL4640019)Show SMILES OCc1cncc(c1)-c1ccc2[nH]nc(C(=O)NCC3CCOCC3)c2c1 Show InChI InChI=1S/C20H22N4O3/c25-12-14-7-16(11-21-9-14)15-1-2-18-17(8-15)19(24-23-18)20(26)22-10-13-3-5-27-6-4-13/h1-2,7-9,11,13,25H,3-6,10,12H2,(H,22,26)(H,23,24) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | <10 | n/a | n/a | n/a | n/a | n/a | n/a |
Angelini Pharma S.p.A.
Curated by ChEMBL
| Assay Description
Inhibition of human LynB using His-tagged Rb truncated protein as substrate incubated for 30 mins in presence of ATP at Km concentration by HTRF assa... |
ACS Med Chem Lett 11: 825-831 (2020)
Article DOI: 10.1021/acsmedchemlett.9b00633
BindingDB Entry DOI: 10.7270/Q2930XQ1 |
More data for this
Ligand-Target Pair | |
Glycogen synthase kinase-3 alpha
(Homo sapiens (Human)) | BDBM50540741
(CHEMBL4640019)Show SMILES OCc1cncc(c1)-c1ccc2[nH]nc(C(=O)NCC3CCOCC3)c2c1 Show InChI InChI=1S/C20H22N4O3/c25-12-14-7-16(11-21-9-14)15-1-2-18-17(8-15)19(24-23-18)20(26)22-10-13-3-5-27-6-4-13/h1-2,7-9,11,13,25H,3-6,10,12H2,(H,22,26)(H,23,24) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | <10 | n/a | n/a | n/a | n/a | n/a | n/a |
Angelini Pharma S.p.A.
Curated by ChEMBL
| Assay Description
Inhibition of human recombinant GSK3alpha using Ulight-CFFKNIVTPRTPPPSQGK-amide as substrate incubated for 60 mins in presence of ATP at Km concentra... |
ACS Med Chem Lett 11: 825-831 (2020)
Article DOI: 10.1021/acsmedchemlett.9b00633
BindingDB Entry DOI: 10.7270/Q2930XQ1 |
More data for this
Ligand-Target Pair | |
Beta-adrenergic receptor kinase 1
(Homo sapiens (Human)) | BDBM50540741
(CHEMBL4640019)Show SMILES OCc1cncc(c1)-c1ccc2[nH]nc(C(=O)NCC3CCOCC3)c2c1 Show InChI InChI=1S/C20H22N4O3/c25-12-14-7-16(11-21-9-14)15-1-2-18-17(8-15)19(24-23-18)20(26)22-10-13-3-5-27-6-4-13/h1-2,7-9,11,13,25H,3-6,10,12H2,(H,22,26)(H,23,24) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | 11 | n/a | n/a | n/a | n/a | n/a | n/a |
Angelini Pharma S.p.A.
Curated by ChEMBL
| Assay Description
Inhibition of human GRK2 in presence of ATP |
ACS Med Chem Lett 11: 825-831 (2020)
Article DOI: 10.1021/acsmedchemlett.9b00633
BindingDB Entry DOI: 10.7270/Q2930XQ1 |
More data for this
Ligand-Target Pair | |
Dual specificity protein kinase CLK1
(Homo sapiens (Human)) | BDBM50540741
(CHEMBL4640019)Show SMILES OCc1cncc(c1)-c1ccc2[nH]nc(C(=O)NCC3CCOCC3)c2c1 Show InChI InChI=1S/C20H22N4O3/c25-12-14-7-16(11-21-9-14)15-1-2-18-17(8-15)19(24-23-18)20(26)22-10-13-3-5-27-6-4-13/h1-2,7-9,11,13,25H,3-6,10,12H2,(H,22,26)(H,23,24) | PDB
MMDB
KEGG
UniProtKB/SwissProt
B.MOAD
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | 13 | n/a | n/a | n/a | n/a | n/a | n/a |
Angelini Pharma S.p.A.
Curated by ChEMBL
| Assay Description
Inhibition of human CLK1 in presence of ATP |
ACS Med Chem Lett 11: 825-831 (2020)
Article DOI: 10.1021/acsmedchemlett.9b00633
BindingDB Entry DOI: 10.7270/Q2930XQ1 |
More data for this
Ligand-Target Pair | |
Cyclin-A2/Cyclin-dependent kinase 2
(Homo sapiens (Human)) | BDBM50540741
(CHEMBL4640019)Show SMILES OCc1cncc(c1)-c1ccc2[nH]nc(C(=O)NCC3CCOCC3)c2c1 Show InChI InChI=1S/C20H22N4O3/c25-12-14-7-16(11-21-9-14)15-1-2-18-17(8-15)19(24-23-18)20(26)22-10-13-3-5-27-6-4-13/h1-2,7-9,11,13,25H,3-6,10,12H2,(H,22,26)(H,23,24) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | 27 | n/a | n/a | n/a | n/a | n/a | n/a |
Angelini Pharma S.p.A.
Curated by ChEMBL
| Assay Description
Inhibition of human CDK2/cyclinA using Ulight-CFFKNIVTPRTPPPSQGK-amide as substrate incubated for 30 mins in presence of ATP by LANCE assay |
ACS Med Chem Lett 11: 825-831 (2020)
Article DOI: 10.1021/acsmedchemlett.9b00633
BindingDB Entry DOI: 10.7270/Q2930XQ1 |
More data for this
Ligand-Target Pair | |
Glycogen synthase kinase-3 beta
(Homo sapiens (Human)) | BDBM50540741
(CHEMBL4640019)Show SMILES OCc1cncc(c1)-c1ccc2[nH]nc(C(=O)NCC3CCOCC3)c2c1 Show InChI InChI=1S/C20H22N4O3/c25-12-14-7-16(11-21-9-14)15-1-2-18-17(8-15)19(24-23-18)20(26)22-10-13-3-5-27-6-4-13/h1-2,7-9,11,13,25H,3-6,10,12H2,(H,22,26)(H,23,24) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | 3.40E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Angelini Pharma S.p.A.
Curated by ChEMBL
| Assay Description
Inhibition of GSK3beta (unknown origin) transfected in HEK cells co-transfected with tau assessed as reduction in tau phosphorylation incubated for 1... |
ACS Med Chem Lett 11: 825-831 (2020)
Article DOI: 10.1021/acsmedchemlett.9b00633
BindingDB Entry DOI: 10.7270/Q2930XQ1 |
More data for this
Ligand-Target Pair | |
Potassium voltage-gated channel subfamily H member 2
(Homo sapiens (Human)) | BDBM50540741
(CHEMBL4640019)Show SMILES OCc1cncc(c1)-c1ccc2[nH]nc(C(=O)NCC3CCOCC3)c2c1 Show InChI InChI=1S/C20H22N4O3/c25-12-14-7-16(11-21-9-14)15-1-2-18-17(8-15)19(24-23-18)20(26)22-10-13-3-5-27-6-4-13/h1-2,7-9,11,13,25H,3-6,10,12H2,(H,22,26)(H,23,24) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | >1.00E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Angelini Pharma S.p.A.
Curated by ChEMBL
| Assay Description
Inhibition of human ERG expressed in CHOK1 cells assessed as reduction in tail current by measuring tail current amplitude measured after deploarizat... |
ACS Med Chem Lett 11: 825-831 (2020)
Article DOI: 10.1021/acsmedchemlett.9b00633
BindingDB Entry DOI: 10.7270/Q2930XQ1 |
More data for this
Ligand-Target Pair | |